Targeting HIV-1 protease: A test of drug-design methodologies
- 28 February 1995
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 16 (2), 67-75
- https://doi.org/10.1016/s0165-6147(00)88980-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- HIV Protease as an Inhibitor Target for the Treatment of AIDSPublished by Elsevier ,1994
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 proteaseAntimicrobial Agents and Chemotherapy, 1993
- Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsAntimicrobial Agents and Chemotherapy, 1992
- Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseAntimicrobial Agents and Chemotherapy, 1991
- Structure and Function of Retroviral ProteasesAnnual Review of Biophysics, 1991
- The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDSTrends in Biochemical Sciences, 1990
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- Structure of Complex of Synthetic HIV-1 Protease with a Substrate-Based Inhibitor at 2.3 Å ResolutionScience, 1989
- Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 ProteaseScience, 1989